Science Explorer Back to mapMap
Discussion
Researcher · Taiho Pharmaceutical (Japan) · Japan

Hiroshi Sootome

Hiroshi Sootome publishes mostly in Molecular Biology, Oncology and Cell Biology, on topics such as Fibroblast Growth Factor Research, Microtubule and mitosis dynamics and Cancer-related Molecular Pathways.

OpenAlex
World rank
#2,640,540
of 7,710,434 ranked researchers
Rank in Japan
#54,970
of 383,136
Works
59
Citations
1.4k
Citations per work
23.4
h-index
9
i10-index 9Top 82% in Molecular Biology
Hiroshi Sootome

What does Hiroshi Sootome research?

Hiroshi Sootome's work is mostly in Biochemistry, Genetics and Molecular Biology (60%), Medicine (28%).

Life Sciences: 35 works · 60.0% of their workBiochemistry, Genetics and Molecular Biology: 35 works · 60.0% of their workMolecular Biology: 25 works · 42.4% of their workCell Biology: 8 works · 12.9% of their workCancer Research: 3 works · 4.7% of their workHealth Sciences: 17 works · 28.2% of their workMedicine: 17 works · 28.2% of their workOncology: 8 works · 14.1% of their workRheumatology: 5 works · 8.2% of their workPulmonary and Respiratory Medicine: 3 works · 5.9% of their workEverything else: 7 works · 11.8% of their workTHEIR WORKHiroshi Sootome59works
Life Sciences60%Health Sciences28%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology3560.0%
    1. Medicine1728.2%
  3. Everything else711.8%
  1. 1Molecular Biology42% of their works
  2. 2Oncology14% of their works
  3. 3Cell Biology13% of their works
  4. 4Rheumatology8% of their works
  5. 5Pulmonary and Respiratory Medicine6% of their works
  6. 6Cancer Research5% of their works

Research topics

Which keywords describe Hiroshi Sootome's research?

The keywords of their largest research topics: Cancer Therapy, FGF21, Fibroblast Growth Factor, Cell Division, Microtubules, Cell Cycle, p53 and Fusion Genes.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Cancer Therapy234 topics
  2. FGF21141 topic
  3. Fibroblast Growth Factor141 topic
  4. Cell Division111 topic
  5. Microtubules111 topic
  6. Cell Cycle61 topic
  7. p5361 topic
  8. Fusion Genes51 topic
  9. Hypereosinophilic Syndrome51 topic
  10. Chemotherapy-Induced Peripheral Neuropathy41 topic
  11. HIF-141 topic
  12. Taxanes41 topic
  13. Warburg Effect41 topic
  14. Molecular Chaperones31 topic
  15. Proteasome31 topic
  16. Protein Folding31 topic
  17. Ubiquitin31 topic

Where does Hiroshi Sootome work?

Hiroshi Sootome's main affiliation in the publication record is Taiho Pharmaceutical (Japan), Japan.

How many publications and citations does Hiroshi Sootome have?

OpenAlex counts 59 works and 1,381 citations for Hiroshi Sootome, an h-index of 9, ranking #2,640,540 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Hiroshi Sootome. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.